Stay updated on Chemotherapy vs. Locoregional Therapy in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemotherapy vs. Locoregional Therapy in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemotherapy vs. Locoregional Therapy in Head and Neck Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:25:50.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents the administration of a carboplatin, nab-paclitaxel, and nivolumab combination for three cycles of three weeks duration each in a clinical trial for patients with head and neck cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:20:34.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for the study. It now specifies that patients must have pathologically confirmed HPV-positive head and neck squamous cell carcinoma of the oropharynx, among other specific health conditions and prior treatments.
    Difference
    45%
    Check dated 2024-05-22T20:31:01.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:14:56.000Z thumbnail image

Stay in the know with updates to Chemotherapy vs. Locoregional Therapy in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemotherapy vs. Locoregional Therapy in Head and Neck Cancer Clinical Trial page.